Lisata Therapeutics, Inc. - LSTA
About Gravity Analytica
Recent News
- 09.29.2025 - Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial
- 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.02.2025 - Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
- 08.07.2025 - Lisata Therapeutics 2nd Quarter 2025 Financial Results and Business Update Conference Call
- 08.07.2025 - Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
- 07.31.2025 - Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
- 07.17.2025 - Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update
- 07.15.2025 - Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
- 06.26.2025 - Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’s Certepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
- 06.17.2025 - 2025 BIO International Convention